Thrombophilic Risk Factors in Preterm and Infants Treated at Ha'Emek Medical Center Between the Years 1990 to 2010
NCT ID: NCT01443273
Last Updated: 2019-11-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2011-10-31
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Risk Factors and Outcome of Thrombosis in Children
NCT05840744
HEMOCC Study. Hemostasis in Cirrhotic Children.
NCT03244332
Otogenic CSVT Retrospective Case Series and Associated Thrombophilia
NCT03864055
Prevalence, Risk Factors and Outcomes of Pediatric Vascular Thrombosis
NCT05889897
Incidence of Venous Thromboembolism in Children Undergoing Elective Neurosurgical Procedures
NCT02037607
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Also the three common genetic factors are analysed including Factor F Leiden (G1691A), Prothrombin Mutation (G20210A) and MTHFR polymorphism (C677T).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Infants with thrombotic events
All infants (premature and term) diagnosed at the Neonatal Intensive Care Unit with thrombotic events
Medical Records study
No interventions will be done related to the study besides summary of the Medical Files.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Medical Records study
No interventions will be done related to the study besides summary of the Medical Files.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1 Year
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
HaEmek Medical Center, Israel
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr Koren Ariel
Head of Pediatric Dpt B and Pediatric Hematology Unit and
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carina Levin, MD
Role: PRINCIPAL_INVESTIGATOR
Pediatric Hematology Unit - Ha'Emek Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pediatric Hematology Unit - HaEmek Medical Center
Afula, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0041-11-EMC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.